HilleVax Reports Second Quarter 2022 Financial Results and Highlights Recent Company Progress
August 10, 2022 16:01 ET | HilleVax, Inc.
BOSTON, Aug. 10, 2022 (GLOBE NEWSWIRE) -- HilleVax, Inc. (Nasdaq: HLVX), a clinical-stage biopharmaceutical company focused on developing and commercializing novel vaccines, today reported financial...
Global Impact launches new $5M research fund - Vaccine Confidence Fund II to further understand how Social Media may be leveraged to Increase Vaccination Confidence and Uptake
August 05, 2022 18:19 ET | Global Impact
Alexandria, VA, Aug. 05, 2022 (GLOBE NEWSWIRE) -- Global Impact, on behalf of the Alliance for Advancing Health Online (AAHO), is pleased to announce the launch of an additional round of Request for...
We The Patriots USA Vows to Make Discrimination Based on Vaccination Status Illegal
August 03, 2022 19:16 ET | We The Patriots USA, Inc.
CALDWELL, Idaho, Aug. 03, 2022 (GLOBE NEWSWIRE) -- We The Patriots USA today announced that its petition to make discrimination based on health status — including vaccination status — illegal has...
Next Move Strategy Consulting.png
Global Biopharmaceutical Market to Generate USD 974.48 Billion by 2030, Outlines a New Report by Next Move Strategy Consulting
August 02, 2022 06:41 ET | Next Move Strategy Consulting
New York, Aug. 02, 2022 (GLOBE NEWSWIRE) -- According to the report published by Next Move Strategy Consulting, the global biopharmaceutical market generated USD 345.84 billion in 2021, and is...
ocugen_4C_LOGO (002).png
Ocugen To Host Conference Call on Friday, August 5 at 8:30 a.m. ET to Discuss Business Updates and Second Quarter 2022 Financial Results
July 29, 2022 07:30 ET | Ocugen
MALVERN, Pa., July 29, 2022 (GLOBE NEWSWIRE) -- Ocugen, Inc. (“Ocugen” or the “Company”) (NASDAQ: OCGN), a biotechnology company focused on discovering, developing, and commercializing novel cell and...
HilleVax Announces Results from 5-Year Clinical Study Supporting Long-Term Immunogenicity of HIL-214 Norovirus Vaccine Candidate
July 20, 2022 16:05 ET | HilleVax, Inc.
Pan-Ig and HBGA blocking antibody responses persisted to year 5 No adverse events deemed related to HIL-214 BOSTON, July 20, 2022 (GLOBE NEWSWIRE) -- HilleVax, Inc. (Nasdaq: HLVX), a...
We the Patriots USA Announces Victory for Alisa Campau, Girl Denied Kidney Transplant for Refusing Covid Shot
July 08, 2022 16:49 ET | We The Patriots USA, Inc.
GRAND RAPIDS, Mich., July 08, 2022 (GLOBE NEWSWIRE) -- On May 13, 2022, a federal lawsuit funded by We The Patriots USA, Inc. (WTP USA) was filed in the Western District of Michigan against Spectrum...
Recombinant DNA Technology is expected to reach a valuation of USD 1.378 trillion by 2030.
New York, United States, July 07, 2022 (GLOBE NEWSWIRE) -- The factors accelerating the market’s growth are high investments in Research and Development, the quick adoption of the genetically...
190705_Biontech_Logo_RGB_Dark Green (Preferred)_0.png
Pfizer and BioNTech Announce Omicron-Adapted COVID-19 Vaccine Candidates Demonstrate High Immune Response Against Omicron
June 25, 2022 10:02 ET | BioNTech SE
Omicron-adapted monovalent candidate given as a fourth booster dose elicited a 13.5 and 19.6-fold increase in neutralizing geometric titers against Omicron BA.1 at 30 µg and 60 µg dose levels;...
New to The Street TV / Newsmax TV Announces its Six Interviews for This Week's TV Broadcast, Episode #358, June 26, 2022, 10-11 AM ET
June 24, 2022 09:30 ET | FMW Media Works Corp
NEW YORK, June 24, 2022 (GLOBE NEWSWIRE) -- FMW Media's New To The Street / Newsmax TV show announces the broadcasting line-up of its national syndicated 1-hour TV show this Sunday, June 26, 2022,...